Medical weight management
Clinician-reviewed compounded semaglutide and tirzepatide programs are advertised, subject to eligibility.
Provider source ↗
Virtual provider · Telehealth available
Provider overview
PepScribe describes itself as a telehealth practice connecting customers with US-licensed clinicians and partner 503A pharmacies. Its public site says it is not a pharmacy. This unclaimed profile records provider-published services and sourcing language; no unnamed pharmacy partner is independently identified here.
At a glance
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Provider-advertised services, grouped for quick scanning with all details visible.
Clinician-reviewed compounded semaglutide and tirzepatide programs are advertised, subject to eligibility.
Provider source ↗The public catalog includes sermorelin, NAD+, recovery, longevity, and body-composition program pathways.
Provider source ↗TRT, enclomiphene, and women’s hormone-care programs are listed among available treatment areas.
Provider source ↗The provider lists sexual-health, hair-loss, and skin-related prescription programs.
Provider source ↗Coverage and research
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Evidence
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
Supports: identity services and 503a pathway · Checked Jul 20, 2026